Document Detail


A necrotic skin lesion in a dialysis patient after the initiation of warfarin therapy: a difficult diagnosis.
MedLine Citation:
PMID:  19267184     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Necrotic skin lesions are unfortunately common in patients with end stage renal disease undergoing dialysis therapy. We present a case of a necrotic skin lesion in a peritoneal dialysis patient shortly after the initiation of warfarin therapy for atrial fibrillation. We discuss and contrast distinguishing features of two diagnostic possibilities: warfarin skin necrosis (WSN) and calcific uremic arteriopathy (CUA) in terms of clinical presentation, risk factors and pathology. Lastly, we outline the importance of establishing a diagnosis as treatment regimens differ substantially.
Authors:
Marie Antoinette Rockx; Manish M Sood
Related Documents :
23824404 - Rapid on-site evaluation reduces needle passes in endoscopic ultrasound-guided fine-nee...
23133604 - The prognosis of allocentric and egocentric neglect: evidence from clinical scans.
24030234 - Overcoming challenges in ibd management: management of colonic dysplastic lesions.
23906594 - Migraine: mimics, borderlands and chameleons.
20950614 - Endoscopic ultrasonography-guided ethanol lavage with paclitaxel injection treats patie...
24315624 - Stress amplifications in dental non-carious cervical lesions.
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2009-03-07
Journal Detail:
Title:  Journal of thrombosis and thrombolysis     Volume:  29     ISSN:  1573-742X     ISO Abbreviation:  J. Thromb. Thrombolysis     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2009-12-24     Completed Date:  2010-04-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9502018     Medline TA:  J Thromb Thrombolysis     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  130-3     Citation Subset:  IM    
Affiliation:
Department of Medicine, Section of Nephrology, St. Boniface Hospital, University of Manitoba, Rm #BG007, 409 Tache Avenue, Winnipeg, MB, R2H 2A6, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anticoagulants / adverse effects*
Calciphylaxis / diagnosis
Diabetic Nephropathies / complications*
Diagnosis, Differential
Humans
Kidney Failure, Chronic / complications*
Male
Middle Aged
Necrosis
Skin Diseases / chemically induced*,  pathology
Warfarin / adverse effects*
Chemical
Reg. No./Substance:
0/Anticoagulants; 81-81-2/Warfarin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cel...
Next Document:  MDR1 haplotypes conferring an increased expression of intestinal CYP3A4 rather than MDR1 in female l...